Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ampio, Astellas, Beigene, Biontech, Clarity, Eagle, Eli Lilly, Everest Medicines, GC, Glaxosmithkline, Hutchmed, Kyowa Kirin, Pfizer, RDIF, R-Pharm Germany, Vir.